Pancreatic Cancer Research

ResearcherChinese PLA General HospitalActive in the last 2 years

Lianyong Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0852-7005; OpenAlex author ID A5038704805. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 2 papers

Papers 3

  1. Current Organoid Culture Systems in Pancreatic Cancer. Last author DOI 10.2174/0115680266392238250423115420↗
  2. Establishing Pancreatic Cancer Organoids from EUS-Guided Fine-Needle Biopsy Specimens. Last author DOI 10.3390/cancers17040692↗
  3. Dimethylaminomicheliolide (DMAMCL) Inhibits Cell Proliferation and Increases Apoptosis and Efficacy of Gemcitabine via Annexin A2 in Pancreatic Adenocarcinoma Co-author DOI 10.21203/rs.3.rs-737712/v1↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Meijuan Wang · 1 shared paper, 2025 · strength 0.27
  2. Chao Gao · 1 shared paper, 2025 · strength 0.27
  3. Lei Liu · 1 shared paper, 2025 · strength 0.26
  4. Yanling Liu · 1 shared paper, 2021 · strength 0.11
  5. Jing Li · 1 shared paper, 2021 · strength 0.11
  6. Kaihui Liu · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.